Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
Article
Workers’ Comp Transformation and the Pandemic: 2020 Trends and Insights from the mPower Conference
COVID-19 has caused many changes throughout 2020, including in the workers’ compensation industry, with many employees leaving the office and worki
Auto Casualty
Article
Managing Third Party Auto Claim Trends During COVID-19
Fewer cars on the road, increasing accident severity, an uncertain economy—these are just a few of the unprecedented challenges the auto insurance
Auto Casualty
News Release
Managing Third Party Auto Claim Trends During COVID-19
Mitchell
News Release
FDA Authorizes Use of First at Home COVID-19 Test Kit
On November 17, 2020, the US Food and Drug Administration has
Mitchell
News Release
Colorado Adopts New Prior Authorization and Payment Timeframes
The Colorado Division of Workers' Compensation recently revised Rule 16: Utilization Standards from the Workers' Compensation Rules of Procedure, w
Workers' Comp
Podcast
Ancillary provider's role in catastrophic claims
In workers’ compensation, catastrophic claims often require a lot of ancillary services which are extremely vital to an injured employee’s recovery